Kristen Harrington-Smith
Director/Board Member chez EFFECTOR THERAPEUTICS, INC.
Fortune : 733 000 $ au 31/01/2024
Provenance du réseau au premier degré de Kristen Harrington-Smith
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Biotechnology | 17 | |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
| Public Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kristen Harrington-Smith via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Miscellaneous Commercial Services | Chairman | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| RADIUS HEALTH, INC. | Biotechnology | Director of Finance/CFO | |
| XENCOR, INC. | Biotechnology | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Alkahest, Inc.
 Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Biotechnology | Director of Finance/CFO | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Pomona College offers curriculum in the arts, humanities, social sciences and natural sciences. It was founded in 1887 and it is headquartered in Claremont, CA | College/University | Director/Board Member Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Corporate Officer/Principal Graduate Degree | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The private company is based in Breda, Netherlands. | Medical Distributors | Director of Finance/CFO Corporate Officer/Principal | |
Auven Therapeutics Management LLLP
 Auven Therapeutics Management LLLP Investment ManagersFinance Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP. | Investment Managers | Founder Private Equity Investor | |
Auven Therapeutics Holdings LP
 Auven Therapeutics Holdings LP Investment ManagersFinance Auven Therapeutics Holdings LP invests in late stage companies developing therapeutic products (small-molecules & biologics) and related diagnostics. It provides financing for buyouts and late stage capital requirements. It makes controlling investments. | Investment Managers | Founder Chief Executive Officer | |
ADC Products (UK) Ltd.
 ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Founder Director/Board Member Director/Board Member | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member Corporate Officer/Principal Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| APPLIED MOLECULAR TRANSPORT INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| RAFAEL HOLDINGS, INC. | Real Estate Development | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
ADC Therapeutics (UK) Ltd.
 ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The private company is based in Reading, UK and was founded in 2014. | Biotechnology | Director/Board Member Director/Board Member | |
Lakewood-Amedex, Inc.
 Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| RUBIUS THERAPEUTICS | Biotechnology | Director of Finance/CFO | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 38 |
| Royaume-Uni | 5 |
| Suisse | 2 |
| Allemagne | 2 |
| France | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 214 |
| Corporate Officer/Principal | 128 |
| Independent Dir/Board Member | 68 |
| Director of Finance/CFO | 38 |
| Undergraduate Degree | 36 |
Relations les plus connectées
| Insiders | |
|---|---|
| Stephen Evans-Freke | 34 |
| Jon Root | 28 |
| Christopher Ehrlich | 26 |
| Jennifer Doudna | 26 |
| Jean Bizzari | 24 |
| Jacques Theurillat | 22 |
| Viviane Monges | 21 |
| Michael Hodges | 21 |
| John Smither | 20 |
| Brian Gallagher | 20 |
| Michael Forer | 18 |
| Christopher Martin | 18 |
| Caroline Loewy | 17 |
| Tyrell J. Rivers | 15 |
| Robert Azelby | 15 |
- Bourse
- Insiders
- Kristen Harrington-Smith
- Connexions Sociétés
